Metoclopramide inhibits proliferation of leukemia stem cells
2021-01-27
(Press-News.org) Chronic myeloid leukemia (CML) results from a degeneration of the hematopoietic stem cells (leukemia stem cells), thereby leading to the uncontrolled formation of specific white blood cells, the so-called granulocytes. Research work at the Department of Medical Oncology at the Inselspital, Bern University Hospital and the University of Bern focused therefore on identifying the signaling pathways and control mechanisms of the leukemia stem cell. A promising approach is provided by working with MPR, an anti-emetic medication commonly used to treat nausea and vomiting.
Specific blocking of leukemia stem cell proliferation with metoclopramide
The exact role of the surface molecule CD93 (cluster of differentiation 93) in controlling the proliferation of leukemia stem cells was analyzed and documented, initially in animal experiments and subsequently in experiments with leukemia stem cells from patients. This revealed a distinct regulatory function of CD93 in leukemia stem cells. To begin with, the effect was demonstrated in vivo in animal experiments. It was further shown that the control function only applies to leukemia stem cells, not to normal hematopoietic stem cells. Furthermore, it was demonstrated that the anti-emetic MPR interrupts the signaling pathway that stimulates cell proliferation of leukemia stem cells in vitro and also, in animal experiments, visibly improves survival with CML by blocking the proliferation of leukemia stem cells. This provides strong evidence that MPR may also show positive results in treating CML in humans.
Extensive research
The study presented in this publication involved exceptionally extensive research. This is also true with regard to the interdisciplinary teams participating from the Department of Medical Oncology, the Department for Biomedical Research, the Institute of Cell Biology and the Department of Orthopedic Surgery and Hematology at the Bern University Hospital and the University of Bern. Prof. Dr. sc. nat. Carsten Riether explains: "In order to develop a new, promising approach to combat CML, contributions from numerous disciplines were necessary and different research approaches had to be pursued. In a screening procedure, we elicited the candidate Metoclopramide and were subsequently able to demonstrate its effect on the CD93 signaling pathway in both in-vitro and in-vivo experiments." The research infrastructure in Bern is optimally designed for such major projects. The expertise in fundamental research at the Department for Biomedical Research (DBMR) and in clinical research at the University Hospital are closely linked and can rapidly produce sound results.
What are the next research activities?
The results have pinpointed CD93 as a specific regulator responsible for leukemia stem cell proliferation. This identifies a promising pathway to targeting leukemia stem cells. Further studies must now prove the clinical effect and relevance. Prof. Adrian Ochsenbein outlines the following picture: "Thanks to this pool of expertise, we were able to identify Metoclopramide as a promising candidate for CML therapy. And with the broad-based research infrastructure and our excellent national and international network, we are hopefully in a position to present clinical results within a reasonable timescale.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2021-01-26
A multidisciplinary team of researchers at the University of Massachusetts Amherst's Institute for Applied Life Sciences (IALS) have developed a technique to replicate bone tissue complexity and bone remodeling processes. This breakthrough could help researchers further their study of bone biology and assist in improving development of drugs for osteoporosis.
Published in Science Advances, the researchers developed a new biomaterial they call demineralized bone paper. The team includes Jungwoo Lee, Yongkuk Park, Ryan Carpenter, chemical engineering; Eugene Cheong, ...
2021-01-26
Our cells are filled with 'bones,' in a sense. Thin, flexible protein strands called actin filaments help support and move around the bulk of the cells of eukaryotes, which includes all plants and animals. Always on the go, actin filaments constantly grow, shrink, bind with other things, and branch off when cells move.
Supercomputer simulations have helped solve the mystery of how actin filaments polymerize, or chain together. This fundamental research could be applied to treatments to stop cancer spread, develop self-healing materials, and more.
"The major findings ...
2021-01-26
A compound that extends lifespan in a tiny nematode worm slows bone loss in aging mice. That surprising result comes from a longitudinal and functional study of 700 aging mice at the Buck Institute, a project that provides a treasure trove of data for researchers aiming to develop therapeutics to slow aging and age-related diseases. The study is currently online in the Journal of Bone and Mineral Research Plus.
The project, which involved five Buck labs and took several years to complete, involved serially profiling the individual mice as they aged while testing several therapeutics that extended lifespan in simple model organisms ...
2021-01-26
Black children have significantly higher rates of shellfish and fish allergies than white children, confirming that race plays an important role in how children are affected by food allergies, researchers at Rush University Medical Center have found. Results of the study were published in the February issue of the Journal of Allergy and Clinical Immunology: In Practice.
"Food allergy is a common condition in the U.S., and we know from our previous research that there are important differences between African-American and white children with food allergy, but there is so much we need to know to be able to help our patients from minority groups," said Dr. Mahboobeh Mahdavinia, who is lead author of the ...
2021-01-26
A research team from the CHUM Research Centre (CRCHUM) has shown that women who have had serious complications during pregnancy are twice as likely to die up to three decades later.
Serious conditions such as stroke, cardiac complications, acute kidney failure and pre-eclampsia affect just under 5 % of women during pregnancy and childbirth.
In a study published in Obstetrics & Gynecology, CRCHUM researcher Dr. Nathalie Auger and postdoctoral fellow Ugochinyere Vivian Ukah examined the long-term mortality risks of women with these types of pregnancy complications by analyzing more than 1.2 million records of women who gave birth in Quebec between 1989 and 2016.
Their findings? Compared to women who had no serious pregnancy complications, women ...
2021-01-26
In 2012, four-year-old Bertrand Might became the first-ever patient diagnosed with a rare genetic disorder called N-glycanase (NGLY1) deficiency. The discovery of this condition and Bertrand's diagnosis allowed doctors to look for other children with the same genetic defect. Since then, more than 60 additional patients have been found. The disease affects every system of the body and is characterized by low muscle tone, seizures, developmental delays, and an inability to produce tears.
Sadly, Bertrand passed away in October at the age of 12. Although his life was cut short, his legacy will benefit children around the world. Through ...
2021-01-26
A recent study of drugged driving, by a team of University of Cincinnati researchers, shows that a sizable percentage of individuals reported the use of marijuana and other illicit drugs while operating behind the wheel.
"We need to focus our efforts on drugged driving, in addition to drunk driving, because drugged driving causes such a high level of fatalities, says Andrew Yockey, a doctoral student in UC's College of Education, Criminal Justice and Human Services and researcher at the UC Center for Prevention Science.
Yockey is lead author on the study ...
2021-01-26
New Rochelle, NY, January 26, 2021--Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. These outcomes, derived from the International Diabetes Closed-Loop (iDCL) Trial, are reported in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT). Click here to read the article now.
Adolescents and young adults with a mean age of 17 years were randomly assigned to a closed-loop control (CLC) insulin delivery system or a sensor augmented pump (SAP) with a continuous glucose monitoring system over a 6-month period. The Time in Range increased by 13% for the CLC group, compared to a decrease of 1% with SAP, for a group ...
2021-01-26
Burning fossil fuels has long powered world economies while contributing to air pollution and the buildup of greenhouse gases. A new analysis of nearly two decades of satellite data shows that economic development, fossil-fuel combustion and air quality are closely linked on the continental and national scales, but can be decoupled at the national level, according to Penn State scientists.
"We know air pollution and economic development are linked, but we want to know how tightly and whether our actions can change this," said Ruixue Lei, a post-doctoral researcher in the Department of Meteorology and Atmospheric Science. "We found they are not inherently bonded and can be decoupled under favorable policies."
While previous research has explored the connections between air ...
2021-01-26
Researchers at Weill Cornell Medicine and Cornell University's Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
The research, published Jan. 7 in The American Journal of Human Genetics, makes the process of finding these interactions much less difficult and demonstrates their importance in determining body mass index and diabetes risk.
"Our study demonstrates that your genes matter and the environment matters and that the interaction of the two can increase risk for disease," said co-senior author, Dr. Olivier ...
LAST 30 PRESS RELEASES:
[Press-News.org] Metoclopramide inhibits proliferation of leukemia stem cells
